Atlanta, GA, United States of America

Matthew Sarcopski

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lonza Inc.. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew Sarcopski

Introduction

Matthew Sarcopski is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of biotechnology, particularly in the area of cell culture-based production of biologics. His innovative work has led to the development of a patented system that enhances the efficiency and control of bioreactor operations.

Latest Patents

Matthew Sarcopski holds a patent for a "System and method for regulating cell culture based production of biologics." This patent focuses on a comprehensive approach to controlling bioreactors and related equipment within a plant. The system includes three main components: hardware, software, and instrument control loops. These components work together to maintain optimal process values, ensuring the effective production of biologics. The patent also incorporates real-time analysis techniques to determine critical parameters, such as the Height Equivalent of a Theoretical Plate (HETP) value and an asymmetry factor.

Career Highlights

Matthew is currently employed at Lonza Inc., a leading company in the life sciences sector. His role involves leveraging his expertise in bioprocessing to drive innovation and improve production methodologies. His work has not only advanced the capabilities of bioreactor systems but has also contributed to the overall efficiency of biologics manufacturing.

Collaborations

Throughout his career, Matthew has collaborated with notable colleagues, including Rex Polley and Robert Horton. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge solutions in the field of biotechnology.

Conclusion

Matthew Sarcopski's contributions to the field of biotechnology through his innovative patent and work at Lonza Inc. highlight his commitment to advancing the production of biologics. His expertise and collaborative efforts continue to shape the future of bioprocessing.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…